These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Is there a relation between the presence in the serum of patients with arterial hypertension of a protein component with molecular weight of 15 kD and the inhibitory effect of the serum on Na,K-ATPase?]. Rogaeva EA; Perova NV; Aleksandrov AA; Oganov RG; Lopina OD Vopr Med Khim; 1987; 33(4):34-9. PubMed ID: 2821695 [TBL] [Abstract][Full Text] [Related]
3. The relation of the natriuretic hormone to essential hypertension. de Wardener HE; MacGregor GA Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538 [TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical approach of a circulating Na+-pump inhibitor. Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634 [TBL] [Abstract][Full Text] [Related]
5. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies. Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183 [TBL] [Abstract][Full Text] [Related]
6. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients. Vasdev S; Fernandez PG; Longerich L; Gault H Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501 [TBL] [Abstract][Full Text] [Related]
8. [Affinity chromatography for the detection of human endogenous inhibitor of NA+, K+ -ATPase]. Henning G; Cloix JF C R Seances Acad Sci III; 1983; 297(6):295-8. PubMed ID: 6318931 [TBL] [Abstract][Full Text] [Related]
9. [Transmembrane Na+ transport kinetics in arterial hypertension: relations with vascular risk parameters]. Caballero Oliver A; Stiefel García-Junco P; García-Donas López MA; Villar Ortiz J; Carneado de la Fuente J Med Clin (Barc); 1995 Dec; 105(20):768-73. PubMed ID: 8558976 [TBL] [Abstract][Full Text] [Related]
10. Recent progress on an endogenous digitalislike factor in hypertension. Cloix JF; Crabos M; Meyer P J Clin Hypertens; 1986 Jun; 2(2):93-100. PubMed ID: 3020179 [TBL] [Abstract][Full Text] [Related]
11. Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism. Delva P; Degan M; Capra C; Fallo F; Mantero F; Menegazzi M; Lechi C; Steele A; Lechi A Miner Electrolyte Metab; 1989; 15(5):315-20. PubMed ID: 2554104 [TBL] [Abstract][Full Text] [Related]
12. [Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects]. Krzesinski JM; Potier JP; Godon JP; Rorive GL Arch Mal Coeur Vaiss; 1987 Jun; 80(6):960-5. PubMed ID: 2821949 [TBL] [Abstract][Full Text] [Related]
14. [Na,K-ATPase from the outer kidney medulla of spontaneously hypertensive rats in ontogenesis]. Boldyrev AA; Orlov SN; Svinukhova IA; Stetsiuk NU Vopr Med Khim; 1987; 33(4):56-9. PubMed ID: 2821696 [TBL] [Abstract][Full Text] [Related]
15. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations]. Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238 [TBL] [Abstract][Full Text] [Related]
16. [Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension]. Saitta A; Saitta MN; Messina A; Bonaiuto M; Cinquegrani M; Squadrito G; Castaldo M; Sardo A; Imbalzano E; Squadrito F Minerva Med; 1997; 88(7-8):275-82. PubMed ID: 9304069 [TBL] [Abstract][Full Text] [Related]
17. Assay of a circulating sodium pump inhibitor in patients with essential hypertension and normotensive subjects. Umeda T; Naomi S; Inoue J; Ohno M; Miura F; Hamasaki S; Iwaoka T; Sato T Clin Exp Hypertens A; 1987; 9(7):1209-19. PubMed ID: 3040304 [TBL] [Abstract][Full Text] [Related]
18. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension. Fu Y; Wang S; Lu Z; Li H; Li S Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376 [TBL] [Abstract][Full Text] [Related]
19. Acute hypotensive effect of calcium antagonists and endogenous digitalis-like immunoreactivity in human essential hypertension. Palombo C; Marabotti C; Genovesi-Ebert A; Del Chicca MG; Balzan S; Giaconi S; Fommei E; Gazzetti P; Clerico A; Ghione S J Hypertens Suppl; 1986 Dec; 4(5):S461-4. PubMed ID: 3033184 [TBL] [Abstract][Full Text] [Related]
20. Erythrocyte Na/K flux ratio in relation to sodium intake and a family history of essential hypertension in normotensive children. Uchiyama M; Satokata I J Hum Hypertens; 1993 Feb; 7(1):47-51. PubMed ID: 8383770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]